| | Dr. May Griffith is the key founder and a leading global expert in the field of regenerative medicine, with special interests in biomaterials enhanced or enabled cell-based regeneration. She is Professor of Regenerative Medicine and Director of the Integrative Regenerative Medicine Centre (IGEN) at Linkőping University, Sweden, and an Adjunct Professor at the University of Ottawa, Canada. Dr. Griffith obtained her PhD from the University of Toronto, and completed her postdoctoral fellowship at Harvard Medical School, Boston. She also has an Executive MBA from the University of Ottawa. Dr. Griffith has collaborated on research projects with instutions from all over the world, as well as worked on collaborative research with companies as CooperVision, Unilever, Procter & Gamble, Santen Paharmaceutical, etc. She received numerous awards, including International Association of Advanced Materials Nanomedical Technology Medal of the Year (2011), and Ottawa‘s Centre for Research and Innovation Life Sciences Research Award (2007). She is a member of the Canadian Stem Cell Network. Dr. Griffith has published over 90 papers in refereed scientific journals, reviews, book chapters, has issued patents and has licensed products for commercial application. Dr. Griffith was coordinator of the EU Nanomedicine project "I-CARE" from which UAB Ferentis is a spin-off.
|
 | Dr. Ramūnas Valiokas is the founder and head of the Department of Nanoengineering at the Center for Physical Sciences (CPST) in Vilnius, Lithuania. He obtained his PhD in applied physics at Linköping University, where he continued his work within the University's Biomimetic Materials Science program. He later was a post-doctoral scientist at the Institute of Biochemistry at Frankfurt University and worked in the fields of cell membrane biophysics and biochemistry. Having founded his own laboratory within the CPST in Vilnius in 2004, his current scientific interests include controlled self-assembly, nanotechnology, cell biophysics, micro/nanodevices for cell and tissue engineering and bioanalytics. Dr. Valiokas has served and is current project lead of several EU projects. His role as project lead from CPST in the EU Nanomedicine project, "I-CARE" has led to the creation of the spin-off company, UAB Ferentis.
|
| | Dr. Jaywant Phopase is an Assistant Professor at the Department of Physics, Chemistry and Biology (IFM), at the Linköping University in Sweden. He has a PhD in Synthetic Chemistry from Technische Universität Wien, Austria. His areas of expertise are biomaterials for regenerative medicine, medicinal chemistry and peptidomimetics. He has developed novel “NXO” peptide building blocks that can be used for controllable self-assembly for a range of peptides. These NXO-amino acids are valuable as building blocks that can be efficiently integrated into peptide fragments using both conventional liquid phase peptide synthesis and solid supported synthesis protocols. Dr. Phopase completed a Postdoctoral Research Fellowship at the National Institute for Cellular Biotechnology and School of Chemical Sciences, at Dublin City University in Ireland, and prior to that, he was at the Institute of Applied Synthetic Chemistry, Vienna University of Technology (TU Wien). Dr. Phopase also worked as a research associate at the New Drug Discovery Division of Glenmark Pharmaceuticals in Navi Mumbai, India, before that he was a chemist at Cipla Pharmaceuticals (India’s second largest pharmaceutical company).
|
| | Vygandas Jūras is an investment professional, with more than 20 years of experience in investment management and investment banking, M&A, corporate restructurings, private equity, corporate finance and business development. He manages the company's strategic business development and financial management aspects. His career spans a Vilnius-based investment banking boutique Prime Investment and MP Bank, an Icelandic investment banking group. He headed Strategic development and research department at the largest Lithuanian telecommunications company TEO LT, AB. Vygandas was a partner at BaltCap Management, a regional private equity fund manager. Prior to BaltCap, Vygandas was worked for global management consulting and accounting firms of PricewaterhouseCoopers, Deloitte & Touche and KPMG/Barents Group in Vilnius and Washington DC, as well as internationally in Moldova, Kyrgyzstan and Kazakhstan. Vygandas holds a BA in Political Science from Macalester College, USA and an MSc in Management from the University of Management and Economics (ISM), Lithuania. |
